Literature DB >> 24626151

Secreted Candida parapsilosis lipase modulates the immune response of primary human macrophages.

Adél Tóth1, Tibor Németh1, Katalin Csonka1, Péter Horváth1, Csaba Vágvölgyi1, Csaba Vizler2, Joshua D Nosanchuk3, Attila Gácser1.   

Abstract

Candida parapsilosis is an important opportunistic pathogen with increasing prevalence. Extracellular lipases have been shown to play an important role in the virulence of pathogenic Candida species. However, studying the role of secreted lipase in C. albicans is challenging due to the lack of a mutant strain deficient in all 10 lipase genes. In contrast, we have previously constructed a lipase mutant C. parapsilosis strain lacking both CpLIP1 and CpLIP2, and shown that it has significantly decreased virulence in various infection models, and is killed more efficiently by mouse macrophages. In the present study, we compared the response of human peripheral blood monocyte-derived macrophages to a wild type (wt) as well as a lipase-deficient (lip(-/-)) C. parapsilosis strain that has been previously established in our lab. Although macrophages phagocytosed both strains with similar efficiency, lipase mutants were killed more efficiently according to fluorescent microscopic analysis. The more efficient killing of lip(-/-) cells was confirmed by CFU-determinations. Phagocytosis of wt and lip(-/-)C. parapsilosis was also examined by flow cytometry, revealing that both strains were internelized to the similar extent by macrophages. Additionally, quantitative imaging analysis revealed that the rate of phagolysosome fusion was higher in case of lip(-/-)C. parapsilosis. Interestingly, macrophages stimulated with lip(-/-)C. parapsilosis showed at least 1.5-fold higher expression of TNFα, IL-1β, IL-6, IL-8, and PTGS-2 after 12 h compared with those infected with wt C. parapsilosis, as determined by qRT-PCR. Furthermore, the lip(-/-)C. parapsilosis strain induced significantly higher TNFα, IL-1β, IL-6, and IL-10 protein production in macrophages after 24 h compared with the wt strain. These findings confirm the role of fungal lipases as important virulence factors during C. parapsilosis infection.

Entities:  

Keywords:  Candida; fungal pathogenesis; host–pathogen interaction; immune responses; lipase; macrophages; parapsilosis; virulence; virulence factors

Mesh:

Substances:

Year:  2014        PMID: 24626151      PMCID: PMC4063816          DOI: 10.4161/viru.28509

Source DB:  PubMed          Journal:  Virulence        ISSN: 2150-5594            Impact factor:   5.882


  28 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Pattern recognition receptors and inflammation.

Authors:  Osamu Takeuchi; Shizuo Akira
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

3.  The identification of gene duplication and the role of secreted aspartyl proteinase 1 in Candida parapsilosis virulence.

Authors:  Péter Horváth; Joshua D Nosanchuk; Zsuzsanna Hamari; Csaba Vágvölgyi; Attila Gácser
Journal:  J Infect Dis       Date:  2012-02-01       Impact factor: 5.226

Review 4.  An integrated model of the recognition of Candida albicans by the innate immune system.

Authors:  Mihai G Netea; Gordon D Brown; Bart Jan Kullberg; Neil A R Gow
Journal:  Nat Rev Microbiol       Date:  2008-01       Impact factor: 60.633

5.  IL-8 induces neutrophil chemotaxis predominantly via type I IL-8 receptors.

Authors:  M E Hammond; G R Lapointe; P H Feucht; S Hilt; C A Gallegos; C A Gordon; M A Giedlin; G Mullenbach; P Tekamp-Olson
Journal:  J Immunol       Date:  1995-08-01       Impact factor: 5.422

6.  Secreted lipases of Candida albicans: cloning, characterisation and expression analysis of a new gene family with at least ten members.

Authors:  B Hube; F Stehr; M Bossenz; A Mazur; M Kretschmar; W Schäfer
Journal:  Arch Microbiol       Date:  2000-11       Impact factor: 2.552

7.  The facultative intracellular pathogen Candida glabrata subverts macrophage cytokine production and phagolysosome maturation.

Authors:  Katja Seider; Sascha Brunke; Lydia Schild; Nadja Jablonowski; Duncan Wilson; Olivia Majer; Dagmar Barz; Albert Haas; Karl Kuchler; Martin Schaller; Bernhard Hube
Journal:  J Immunol       Date:  2011-08-17       Impact factor: 5.422

Review 8.  Signalling networks regulating cyclooxygenase-2.

Authors:  Christos Tsatsanis; Ariadne Androulidaki; Maria Venihaki; Andrew N Margioris
Journal:  Int J Biochem Cell Biol       Date:  2006-04-25       Impact factor: 5.085

9.  Mycobacterium tuberculosis phagosome maturation arrest: mycobacterial phosphatidylinositol analog phosphatidylinositol mannoside stimulates early endosomal fusion.

Authors:  Isabelle Vergne; Rutilio A Fratti; Preston J Hill; Jennifer Chua; John Belisle; Vojo Deretic
Journal:  Mol Biol Cell       Date:  2003-11-14       Impact factor: 4.138

10.  Lipolytic enzymes involved in the virulence of human pathogenic fungi.

Authors:  Minji Park; Eunsoo Do; Won Hee Jung
Journal:  Mycobiology       Date:  2013-06-30       Impact factor: 1.858

View more
  12 in total

Review 1.  Clinical and Biological Features of Cutibacterium (Formerly Propionibacterium) avidum, an Underrecognized Microorganism.

Authors:  Stéphane Corvec
Journal:  Clin Microbiol Rev       Date:  2018-05-30       Impact factor: 26.132

Review 2.  Candida parapsilosis: from Genes to the Bedside.

Authors:  Renáta Tóth; Jozef Nosek; Héctor M Mora-Montes; Toni Gabaldon; Joseph M Bliss; Joshua D Nosanchuk; Siobhán A Turner; Geraldine Butler; Csaba Vágvölgyi; Attila Gácser
Journal:  Clin Microbiol Rev       Date:  2019-02-27       Impact factor: 26.132

3.  Candida parapsilosis produces prostaglandins from exogenous arachidonic acid and OLE2 is not required for their synthesis.

Authors:  Zsuzsanna Grózer; Adél Tóth; Renáta Tóth; Anita Kecskeméti; Csaba Vágvölgyi; Joshua D Nosanchuk; András Szekeres; Attila Gácser
Journal:  Virulence       Date:  2015       Impact factor: 5.882

4.  Oral Epithelial Cells Distinguish between Candida Species with High or Low Pathogenic Potential through MicroRNA Regulation.

Authors:  Renáta Tóth; Attila Gácser; Márton Horváth; Gábor Nagy; Nóra Zsindely; László Bodai; Péter Horváth; Csaba Vágvölgyi; Joshua D Nosanchuk
Journal:  mSystems       Date:  2021-05-11       Impact factor: 6.496

5.  Looking into the virulence of Candida parapsilosis: a diagnostic perspective.

Authors:  Oliver Bader
Journal:  Virulence       Date:  2014-04-23       Impact factor: 5.882

6.  Kinetic studies of Candida parapsilosis phagocytosis by macrophages and detection of intracellular survival mechanisms.

Authors:  Renáta Tóth; Adél Tóth; Csaba Papp; Ferenc Jankovics; Csaba Vágvölgyi; Maria F Alonso; Judith M Bain; Lars-Peter Erwig; Attila Gácser
Journal:  Front Microbiol       Date:  2014-11-20       Impact factor: 5.640

7.  Specific pathways mediating inflammasome activation by Candida parapsilosis.

Authors:  Adél Tóth; Erik Zajta; Katalin Csonka; Csaba Vágvölgyi; Mihai G Netea; Attila Gácser
Journal:  Sci Rep       Date:  2017-02-22       Impact factor: 4.379

8.  Lasiodiplodia theobromae as a Producer of Biotechnologically Relevant Enzymes.

Authors:  Carina Félix; Sofia Libório; Mariana Nunes; Rafael Félix; Ana S Duarte; Artur Alves; Ana C Esteves
Journal:  Int J Mol Sci       Date:  2018-01-23       Impact factor: 5.923

9.  Functional Characterization of Secreted Aspartyl Proteases in Candida parapsilosis.

Authors:  Dhirendra Kumar Singh; Tibor Németh; Alexandra Papp; Renáta Tóth; Szilvia Lukácsi; Olga Heidingsfeld; Jiri Dostal; Csaba Vágvölgyi; Zsuzsa Bajtay; Mihály Józsi; Attila Gácser
Journal:  mSphere       Date:  2019-08-21       Impact factor: 4.389

10.  Different Candida parapsilosis clinical isolates and lipase deficient strain trigger an altered cellular immune response.

Authors:  Renáta Tóth; Maria F Alonso; Judith M Bain; Csaba Vágvölgyi; Lars-Peter Erwig; Attila Gácser
Journal:  Front Microbiol       Date:  2015-10-13       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.